With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

medicine
The Art of Recovery: Where Music and Medicine Meet in Patient Care
May 14, 2026

Healthcare today can feel overwhelming—not just for patients, but for the teams caring for them. After a major illness or injury, recovery isn’t handled by one doctor alone; it often involves a whole network of specialists, from physical therapists to nurses to social workers, all trying to help someone regain their independence and quality…

Read More
infant health
From Monitoring to Knowing: How Owlet Is Redefining Infant Health at Retail
May 14, 2026

Baby monitors have long promised parents the ability to see and hear their child from another room. But as connected health devices become more normalized in everyday life, from smartwatches to sleep trackers, parents are beginning to expect more than visibility. They want insight. For Owlet, that shift matters because its wearable monitors track…

Read More
SPD
Unlocking CensisAI²: The Metrics That Matter for Smarter SPD Decisions
May 13, 2026

Sterile processing departments are swimming in data, from workflow automation and supply data to patient outcome and quality metrics. But the real challenge is not collecting more information; it is knowing which metrics actually improve SPD performance, technician education, OR readiness and patient safety. For Censis, a leader in surgical asset management, the focus…

Read More
User-generated content
The New Rules of Discoverability: How User-Generated Content Is Reshaping Search, Trust, and Brand Visibility
May 12, 2026

User-generated content (UGC) is moving from marketing side dish to main course as large language models change how people discover brands, products, creators, and ideas. Customer reviews, forum posts, videos, and community conversations increasingly carry more influence than polished brand copy because they feel more specific, lived-in, and trustworthy. As AI systems learn from…

Read More